cysteine has been researched along with Chronic Hepatitis C in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rino, Y; Yamamoto, N; Yukawa, N | 1 |
Ikegami, T; Matsuzaki, Y; Saito, Y | 1 |
Im, GY; Kazi, S; Perumalswami, PV; Thung, SN | 1 |
Fujioka, T; Iwasaki, T; Kurosaki, Y; Okano, T; Okazaki, T; Taniguchi, M; Yamazaki, K | 1 |
Imazeki, F | 1 |
Yamada, G | 1 |
Del Vecchio Blanco, C; Falciani, M; Federico, A; Filippelli, A; Floreani, A; Loguercio, C; Naccarato, R; Rossi, F; Tiso, A; Tuccillo, C | 1 |
Bernard, NF; Bruneau, J; Huang, KH; Shoukry, N | 1 |
Bernhard, MC; Hettinger, A; Junker, E; Lauterburg, BH | 1 |
Braunschweiger, I; Inchauspé, G; Jung, G; Langhans, B; Sauerbruch, T; Schweitzer, S; Spengler, U | 1 |
De Bie, S; De Paepe, A; De Vos, M; Delanghe, JR; Leroux-Roels, G; Messiaen, L; Praet, M; Van Vlierberghe, H | 1 |
Hayashi, H; Ikeda, R; Imaizumi, Y; Kawanaka, M; Sanae, F; Shiono, Y; Takikawa, T; Wakusawa, S; Yamada, G; Yano, M; Yoshioka, K | 1 |
3 review(s) available for cysteine and Chronic Hepatitis C
Article | Year |
---|---|
Does herbal medicine reduce the risk of hepatocellular carcinoma?
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drugs, Chinese Herbal; Fatty Liver; Fluorenes; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Preparations; Sofosbuvir; Tablets | 2015 |
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
1 trial(s) available for cysteine and Chronic Hepatitis C
Article | Year |
---|---|
Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine.
Topics: Acetylcysteine; Adult; Antiviral Agents; Cysteine; Double-Blind Method; Female; Glutathione; Hepatitis C, Chronic; Homocysteine; Humans; Interferon-alpha; Male; Time Factors | 1998 |
8 other study(ies) available for cysteine and Chronic Hepatitis C
Article | Year |
---|---|
[Alternative therapies for hepatitis C: UDCA and SNMC].
Topics: Cysteine; Drug Combinations; Glycine; Glycyrrhetinic Acid; Hepatitis C, Chronic; Humans; Liver; Ursodeoxycholic Acid | 2011 |
A maxed-out liver: a case of acute-on-chronic liver failure.
Topics: Chemical and Drug Induced Liver Injury; Cysteine; Diagnosis, Differential; End Stage Liver Disease; Hepacivirus; Hepatitis C, Chronic; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Thiazolidines | 2011 |
Cysteine analog breaks cryoprecipitate associated with chronic hepatitis C.
Topics: alpha-2-HS-Glycoprotein; Cryoglobulins; Cysteine; Disulfides; Factor VIII; Fibrinogen; Hepatitis C, Chronic; Humans | 2013 |
Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies.
Topics: Adult; Aged; Aged, 80 and over; Aldehydes; Biomarkers; Blood Platelets; Case-Control Studies; Cysteine; Female; Glutathione; Hepatitis C, Chronic; Humans; Interleukin-6; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Nitrites; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; S-Nitrosoglutathione; S-Nitrosothiols; Thrombocytopenia; Tumor Necrosis Factor-alpha | 2007 |
Spontaneous resolution of hepatitis C virus infection is not due to a mutation at Cys-508 of MAVS/VISA/IPS-1/CARDIF.
Topics: Adaptor Proteins, Signal Transducing; Cysteine; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Immunity, Innate; Multiprotein Complexes; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Viral Nonstructural Proteins | 2008 |
Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro.
Topics: Adult; Cell Culture Techniques; Cell Division; Cysteine; Epitopes, T-Lymphocyte; Female; Hepacivirus; Hepatitis C Antigens; Hepatitis C, Chronic; Humans; Male; Middle Aged; Peptide Fragments; T-Lymphocytes, Helper-Inducer; Viral Core Proteins; Viral Nonstructural Proteins | 2001 |
Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.
Topics: Adult; Aged; Alleles; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Cysteine; Female; Genetic Predisposition to Disease; Genetic Testing; Haptoglobins; Hepatitis C, Chronic; Humans; Male; Middle Aged; Mutation, Missense; Phenotype; Polymorphism, Genetic; Prevalence; Probability; Reference Values; Risk Assessment; Tyrosine | 2001 |
C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
Topics: Adult; Asian People; Aspartic Acid; Cysteine; Female; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Iron Overload; Japan; Liver Diseases; Male; Membrane Proteins; Middle Aged; Point Mutation; Polymerase Chain Reaction; Tyrosine | 2001 |